This page includes the latest FDA filings for Kristen Snaguski. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| Registration Number | 3012234772 | ||||
| FEI Number | 3012234772 | ||||
| Name | Kristen Snaguski | ||||
| Owner & Operator | Pierre Fabre Pharmaceuticals, Inc. | ||||
| Contact Address | 8 Campus Drive 2nd Floor Parsippany NJ 07054 US | ||||
| Official Correspondent |
| ||||
| US Agent |
| ||||
| Importing Logistics Registration |
| ||||
| Registration Status | 1 | ||||
| Initial Importer | N | ||||
| Registration Expiration | 2020-04-25 | ||||
| Registration Address | 8 CAMPUS DR STE 2 Parsippany, NJ 07054 US | ||||
| Establishment Type | Manufacture Medical Device |
Device Company | Device | Date |
|---|---|---|
Kristen Snaguski [Pierre Fabre Pharmaceuticals, Inc.] | DEXERYL | 2016-10-12 |